You are here: Industry Insights > Fujifilm

News List

Fujifilm Acquires Cell Therapy Mfg. Facility from Atara Biotherapeutics contractpharma
January 27, 2022
Expands its advanced therapies CDMO business .
Fujifilm Invests $850M to Expand Biologics Capabilities contractpharma
July 02, 2021
Investment in CDMO business to add development and manufacturing capacity in US and UK.
Fujifilm Selects North Carolina for $2B Bio CDMO Facility contractpharma
March 22, 2021
Fujifilm Corporation said it has selected Holly Springs, NC as the location for its new large-scale cell culture production site in the U.S.
Fujifilm and Sana Biotechnology Enter Cell Therapy Partnership contractpharma
March 18, 2021
Fujifilm Cellular Dynamics, a global developer and manufacturer of human induced pluripotent stem cells (iPSC) technologies, and Sana Biotechnology, a company focused on creating and delivering engineered cells as medicines, have entered a license ...
Fujifilm to launch rapid antigen COVID-19 test in Europe europeanpharmaceuticalreview
March 17, 2021
Having received the CE certificate, Fujifilm can now launch its highly-sensitive, rapid antigen test kit for SARS-CoV-2 in Europe.
Fujifilm Breaks Ground on Major Expansion of Biologics Facility in Denmark contractpharma
March 08, 2021
Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, viral vaccines and viral vectors, held a virtual ground-breaking ceremony to celebrate the start of its large-scale cell culture expansion ...
FUJIFILM Diosynth Hosts UK PM at COVID Vax Mfg. Site contractpharma
February 18, 2021
Billingham site to support the manufacture of up to 180 million doses Novavax’ NVX-CoV2373 COVID-19 vaccine candidate.
Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center contractpharma
January 15, 2021
FUJIFILM Corp. and the Center for Advanced Biological Innovation and Manufacturing (CABIM), have secured $76 million in financing and signed a lease for a 40,000 square-foot site in Watertown, MA.
Fujifilm to Invest $2B in US Manufacturing Site contractpharma
January 08, 2021
Fujifilm Corporation is investing more than $2 billion to establish a new large-scale cell culture production site in the U.S. to accelerate the growth of its biopharmaceutical contract development and manufacturing business.
Fujifilm to Invest $40M in New Facility contractpharma
January 06, 2021
Fujifilm Corporation has announced an investment of approximately $40 million in Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, viral vaccines and viral vectors, to establish a new ...

Previous page 1 2 3 4 5 Next page